In this study, using a rigorously validated anti‐ROCK2 antibody (Appendix Fig S1A), we found that ROCK2 expression increased with tumor progression in human PDAC (Fig 1A) and in mouse pancreatic cancer models (Fig 1F and G). Here, ROCK2 is linked to neoplasm.